Schedule 13D ownership disclosure

Intellia Therapeutics Inc

Security class unavailable · CUSIP: 45826J105

Event date: 2017-11-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-17-000896
Form type
SC 13D/A
Filer
Intellia Therapeutics, Inc.
CIK
CIK 1652130
Filed
Nov 08, 2017
Reporting period
Nov 06, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub